PMID: 3755076Aug 15, 1986Paper

Chemotherapy induces regression of brain metastases in breast carcinoma

Cancer
D RosnerW Lane

Abstract

This study improves treatment options and ultimately survival by using systemic chemotherapy in brain metastases from breast carcinoma, since most of these patients have disseminated disease and a dismal prognosis when treated by conventional brain irradiation alone. One hundred consecutive patients with symptomatic brain metastases documented by radionuclide and/or computerized tomography scan were treated with systemic chemotherapy. Fifty of 100 patients demonstrated an objective response of brain metastases which was similar for extracranial metastases. There were 10 complete responders (CR), 40 partial responders (PR), 9 stable, and 41 nonresponders. Median duration of remission was 10+ months for CR and 7 months for PR (range, 2-72 months). Primary chemotherapy of brain metastases yielded responses in 27 of 52 patients (52%) treated with Cytoxan (cyclophosphamide) (C), 5-fluorouracil (F) and prednisone (P); 19 of 35 (54%) receiving CFP-methotrexate (M) and vincristine (V); 3 of 7 (43%) treated with MVP, and 1 of 6 (17%) receiving Cytoxan plus Adriamycin (doxorubicin) (CA). Thirteen of 35 patients (37%) who subsequently had relapse of brain metastases were retreated successfully with secondary chemotherapy. The median survi...Continue Reading

References

Jan 1, 1977·International Journal of Radiation Oncology, Biology, Physics·F R Hendrickson
Oct 1, 1979·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D Rosner, T Nemoto
Jan 1, 1977·International Journal of Radiation Oncology, Biology, Physics·C B Wilson
Mar 1, 1977·British Journal of Cancer·J L HaywardR D Rubens
Sep 1, 1977·Archives of Neurology·N A VickD D Bigner
Jan 1, 1976·Journal of Surgical Oncology·D RosnerT L Dao
Sep 1, 1975·Human Pathology·A Hirano, T Matsui
Dec 1, 1975·Archives of Neurology·J B Posner, W R Shapiro
Aug 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J HildebrandY Kenis
Dec 1, 1972·Journal of the National Cancer Institute·V A LevinA D Little
Feb 1, 1971·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·L Z NisceF C Chu
Feb 1, 1971·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·J HortonK B Olson
Feb 1, 1967·Angiology·R L Wright
Jan 1, 1980·International Journal of Radiation Oncology, Biology, Physics·J West, M Maor
Jan 1, 1982·Cancer·C J LogothetisA Trindade
Jan 1, 1983·Journal of Neuro-oncology·D RosnerW Lane
Jan 1, 1983·Journal of Neuro-oncology·T L CascinoJ B Posner
Jul 1, 1980·Annals of Internal Medicine·E A Neuwelt, E P Frenkel
Jun 1, 1980·Annals of Neurology·J G CairncrossJ B Posner
Apr 1, 1964·Journal of Neuropathology and Experimental Neurology·F P ALEUL C SCHEINBERG
Jun 1, 1964·The Surgical Clinics of North America·E F LANG, J SLATER
Sep 1, 1962·Journal of Neurosurgery·A J RAIMONDIJ P EVANS

❮ Previous
Next ❯

Citations

Apr 1, 1991·Journal of Neuro-oncology·H PorsM Larsen
Mar 1, 1996·Journal of Neuro-oncology·J B Posner
Jan 1, 1994·World Journal of Surgery·K Wong, I C Henderson
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·C JacquillatJ J Bonerandi
Jan 1, 1995·Journal of Neuro-oncology·D J Stewart, S Dahrouge
Feb 1, 1993·Journal of Neuro-oncology·W BoogerdG Baris
Jan 1, 1992·Journal of Cancer Research and Clinical Oncology·I C KiricutaW Bohndorf
Sep 1, 1988·Breast Cancer Research and Treatment·R ColomerL Salvador
Jan 14, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Shinji OhnoShigeru Murakami
Feb 8, 2008·Cancer Chemotherapy and Pharmacology·Rupert BartschGuenther G Steger
Apr 29, 1998·Journal of Neurology·C J Vecht
Apr 1, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mu-Tai LiuCheng-Hong Liou
Aug 26, 2009·International Journal of Clinical Oncology·Tobias Walbert, Mark R Gilbert
Jun 12, 2002·Current Treatment Options in Oncology·P Y Wen, J S Loeffler
Dec 14, 2011·Current Oncology Reports·Sean A Grimm
Nov 28, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M J Gil-GilS Villà
Dec 15, 2012·CNS Drugs·Rupert BartschMatthias Preusser
Jul 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·W Boogerd
Jun 30, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Tulika Ranjan, Lauren E Abrey
Oct 31, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G SimonováJ Novotný
Aug 26, 1998·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·K Kelly, P A Bunn
Aug 26, 1998·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·V MinottiM Tonato
Oct 3, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J van den Bent
Sep 24, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S LentzschB Dörken
Apr 8, 2011·Nature Reviews. Cancer·Patricia S SteegQuentin R Smith
Jul 31, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I H ParkK H Shin
Jun 1, 1997·American Journal of Clinical Oncology·M ColleoniP Manente
Jul 28, 2001·American Journal of Clinical Oncology·M L WangR L Theriault
Jun 6, 2008·American Journal of Clinical Oncology·David N ChurchChris G A Price
Aug 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·H NakagawaT Hayakawa
Sep 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paul R LockmanQuentin R Smith
Jul 20, 2012·Continuum : Lifelong Learning in Neurology·Christine Lu-Emerson, April F Eichler
Oct 21, 2005·Neurosurgery·David M Peereboom
Apr 4, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Rupert BartschGuenther G Steger
Jul 5, 2007·Neurosurgical Focus·Robert Cavaliere, David Schiff
Jan 29, 2014·Neuro-oncology·David M PeereboomAndrew D Seidman
May 10, 2005·Expert Review of Anticancer Therapy·Michelle E MeliskoJohn W Park
Nov 3, 2006·Expert Review of Neurotherapeutics·Jan Drappatz, Patrick Y Wen
Apr 15, 2006·Expert Review of Anticancer Therapy·Ryan H Engel, Virginia G Kaklamani
Jul 18, 2014·Expert Opinion on Pharmacotherapy·Cagatay ArslanKadri Altundag

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.